Safeguard Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$307K Buy
1,467
+14
+1% +$2.72K 0.07% 83
2024
Q4
$258K Buy
1,453
+25
+2% +$4.6K 0.06% 96
2024
Q3
$282K Sell
1,428
-268
-16% -$50K 0.07% 95
2024
Q2
$291K Buy
1,696
+404
+31% +$66.9K 0.08% 79
2024
Q1
$235K Buy
+1,292
New +$223K 0.08% 75
2023
Q3
Sell
-1,272
Closed -$171K 75
2023
Q2
$171K Buy
1,272
+16
+1% +$2.35K 0.08% 73
2023
Q1
$200K Buy
+1,256
New +$192K 0.12% 68

Other funds holding ABBV

Safeguard Financial's ABBV Position: Q1 2025 in Review

Safeguard Financial increased its AbbVie (ABBV) stake by 0.96% in Q1 2025, buying an estimated $2.72K and bringing the position to 1,467 shares worth $307K. The position accounts for 0.07% of the portfolio, ranked #83.

Safeguard Financial first reported a position in ABBV in Q1 2023 and has held it in 7 quarters since. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Safeguard Financial held 1,467 shares of AbbVie worth $307K as of Q1 2025.
  • Safeguard Financial bought 14 AbbVie shares in Q1 2025, an estimated $2.72K.
  • AbbVie made up 0.07% of Safeguard Financial's portfolio in Q1 2025, its #83 holding.
  • Safeguard Financial first reported a position in AbbVie in Q1 2023 and has held it in 7 quarters since.
  • 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Safeguard Financial's 13F filing for Q1 2025, filed 11 Apr 2025.